Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 4/20 | 0.46 |
| ▸ | MRGPRX1 | Q96LB2 | 2/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 7/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.41 |
| ▸ | IDH1 | O75874 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CCR2 | P41597 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21384560 | 0.95 | MCL1 (0.46) | MCL1MRGPRX1KIF11CNR2CNR1 | |
| SCHEMBL21384550 | 0.90 | MCL1 (0.44) | MCL1MRGPRX1KIF11CNR2CNR1 | |
| SCHEMBL21384576 | 0.81 | MRGPRX1 (0.63) | MRGPRX1IDH1CA12CA1CA2 | |
| SCHEMBL21394361 | 0.76 | MRGPRX1 (0.58) | MRGPRX1IDH1CA12CA1CA2 | |
| SCHEMBL393515 | 0.74 | BRAF (0.40) | MRGPRX1CNR2CNR1CCR2 | |
| SCHEMBL21394560 | 0.74 | MRGPRX1 (0.51) | MRGPRX1CA12CA1CA2CA9 | |
| SCHEMBL21394420 | 0.74 | MRGPRX1 (0.56) | MRGPRX1CA12CA1CA2CA9 | |
| SCHEMBL21394417 | 0.74 | MRGPRX1 (0.53) | MRGPRX1CA12CA1CA2CA9 | |
| SCHEMBL21381357 | 0.73 | MAPT (0.48) | MCL1KIF11CHRNA7CA12CA1 | |
| SCHEMBL21381353 | 0.73 | MRGPRX1 (0.62) | MRGPRX1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019179436-A1 | ACID AMIDE COMPOUND AND USE THEREOF IN TREATMENT OF CANCERS | 成都海创药业有限公司 | 2019-09-26 | — | — | WO | disclosed |